Literature DB >> 8542577

Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma.

C M Gleeson1, J M Sloan, J A McGuigan, A J Ritchie, J L Weber, S E Russell.   

Abstract

Microsatellite alterations have been documented in a subset of sporadic tumors, including those of the colon, lung, bladder, stomach, and esophagus. This study documented the frequency of microsatellite alterations at 139 loci, comprising predominantly dinucleotide and tetranucleotide repeat units, in 17 cases of primary esophageal adenocarcinoma arising against a background of Barrett's metaplasia. Each tumor demonstrated alterations in at least one locus studied. Widespread microsatellite alterations, occurring at 45.3% (58 of 128) of loci tested, were detected in a single case. The remaining 16 tumors exhibited low levels of microsatellite instability, ranging from 0.8% (1 of 128) to 8.1% (10 of 123) of loci tested. The single case with ubiquitous somatic alterations showed no significant difference in the incidence of novel alleles at di- and tetranucleotide repeat loci. The 16 cases showing a low level of microsatellite alterations demonstrated a 3.3-fold higher incidence of novel alleles at tetranucleotide repeat loci compared to dinucleotide repeat loci. These data suggest that ubiquitous somatic alterations at microsatellite loci, considered a phenotypic expression of defective mismatch repair, occur infrequently in Barrett's-associated adenocarcinoma. However, the majority of these tumors demonstrate a low level of microsatellite alterations, perhaps reflecting the inherent instability of these markers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542577

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 3.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 4.  Microsatellite instability in gastrointestinal tract cancers: a brief update.

Authors:  Shinya Oda; Yan Zhao; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

5.  Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers.

Authors:  T Hamamoto; H Yokozaki; S Semba; W Yasui; S Yunotani; K Miyazaki; E Tahara
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

6.  p53 abnormalities in adenocarcinoma of the gastric cardia and antrum.

Authors:  J F Fléjou; V Gratio; F Muzeau; R Hamelin
Journal:  Mol Pathol       Date:  1999-10

7.  Alterations of microsatellite loci GSN and D18S51 in urinary bladder cancer.

Authors:  S Saidi; Z Popov; S Stavridis; S Panov
Journal:  Hippokratia       Date:  2015 Jul-Sep       Impact factor: 0.471

8.  Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.

Authors:  T T Wu; T Watanabe; R Heitmiller; M Zahurak; A A Forastiere; S R Hamilton
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

9.  The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk.

Authors:  Matjaz Vogelsang; Yabing Wang; Nika Veber; Lamech M Mwapagha; M Iqbal Parker
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

10.  Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.

Authors:  L B Koppert; A W van der Velden; M van de Wetering; M Abbou; A M W van den Ouweland; H W Tilanus; B P L Wijnhoven; W N M Dinjens
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.